Literature DB >> 29554812

Clinical applications of optical coherence tomography angiography: What we have learnt in the first 3 years.

Salomon Y Cohen1,2, Alexandra Miere2, Sylvia Nghiem-Buffet1, Franck Fajnkuchen1, Eric H Souied2, Sarah Mrejen1.   

Abstract

A review of the literature from 2014 to 2016 was conducted, focusing on the results of optical coherence tomography angiography in different chorioretinal diseases. In only 3 years, optical coherence tomography angiography has been shown to be an effective tool for diagnosing choroidal neovascularization complicating age-related macular degeneration, pathologic myopia, and inflammatory conditions. The technique has sometimes been considered superior to conventional multimodal imaging, for example, in choroidal neovascularization associated with chronic central serous chorioretinopathy or multifocal choroiditis. In retinal vascular diseases, optical coherence tomography angiography has helped to understand the condition described as paracentral acute middle maculopathy and has been considered highly effective for the analysis of retinal vascular macular changes secondary to retinal vein occlusion or macular telangiectasia. Changes in the foveal avascular zone, also reported in diabetic maculopathy, have been shown to occur before any angiographic signs. A reduction in capillary vascular density has been reported in the fovea of eyes with malignant melanoma, but not in eyes with choroidal nevus. However, optical coherence tomography angiography is a recent technique that probably needs refinements and further studies. Nevertheless, the first 3 years of optical coherence tomography angiography use suggest its clinical relevance and useful applications in daily clinical practice.

Entities:  

Keywords:  Optical coherence tomography; age-related macular degeneration; central serous chorioretinopathy; choroidal neovascularization; choroidal tumors; diabetic macular edema; myopia; optical coherence tomography angiography; retinal vascular occlusion

Mesh:

Year:  2018        PMID: 29554812     DOI: 10.1177/1120672117753704

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  6 in total

Review 1.  Optical coherence tomography angiography-derived flow density: a review of the influencing factors.

Authors:  Viktoria C Brücher; Jens J Storp; Nicole Eter; Maged Alnawaiseh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-09       Impact factor: 3.117

2.  Microvascular Changes in Macular Area After Phacoemulsification and Its Influencing Factors Assessed by Optical Coherence Tomography Angiography.

Authors:  Jun Liu; Qiang Liu; Hua Yu; Ye Xia; Hui Zhang; Chao Geng; Lihong Dong
Journal:  Ther Clin Risk Manag       Date:  2021-05-14       Impact factor: 2.423

3.  Comparison of vascular parameters between normal cynomolgus macaques and healthy humans by optical coherence tomography angiography.

Authors:  Jingyi Peng; Liuxueying Zhong; Li Ma; Jiayi Jin; Yongxin Zheng; Chenjin Jin
Journal:  BMC Ophthalmol       Date:  2019-10-11       Impact factor: 2.209

4.  Reproducibility and Reliability of Spectralis II OCT Angiography Vascular Measurements.

Authors:  Marco R Pastore; Alberto Grotto; Francesca Vezzoni; Andrea Gaggino; Serena Milan; Stefano Gouigoux; Pier Luigi Guerin; Alex L Vinciguerra; Gabriella Cirigliano; Daniele Tognetto
Journal:  Diagnostics (Basel)       Date:  2022-08-07

5.  Retinal and Choroidal Capillary Perfusion Are Reduced in Hypertensive Crisis Irrespective of Retinopathy.

Authors:  Jan Henrik Terheyden; Maximilian W M Wintergerst; Carmen Pizarro; Maximilian Pfau; Gabrielle N Turski; Frank G Holz; Robert P Finger
Journal:  Transl Vis Sci Technol       Date:  2020-07-29       Impact factor: 3.283

6.  Comparison of methods to quantify macular and peripapillary vessel density in optical coherence tomography angiography.

Authors:  Alessandro Rabiolo; Francesco Gelormini; Riccardo Sacconi; Maria Vittoria Cicinelli; Giacinto Triolo; Paolo Bettin; Kouros Nouri-Mahdavi; Francesco Bandello; Giuseppe Querques
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.